EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSMOCG00000018770
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSMOCG00000019118
Gene Symbol: KIF5B
3 Cross references
280 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSMOCG00000007811
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSMOCG00000004054
Gene Symbol: LTB4R
2 Cross references
140 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSMOCG00000003813
Gene Symbol: LTB4R2
3 Cross references
236 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSMOCG00000019521
Gene Symbol: KDM1A
1 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSMOCG00000021272
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Metalloelastase

Ensembl ID : ENSMOCG00000020347
Gene Symbol: LOC101986712
3 Cross references
550 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSMOCG00000016316
Gene Symbol: MIF
3 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor (C-Met-Related Tyrosine Kinase)

Ensembl ID : ENSMOCG00000007271
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSMOCG00000010248
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSMOCG00000006065
Gene Symbol: MMP14
3 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).